NEOGEN

Neogen Chemicals Financial Results

₹2,451.60+0.92%
Market cap
₹6,468 crore
P/E
181.9
P/B
7.92
ROE
3.6%
Dividend yield
0.04%

For the year ended Mar 2019, Neogen Chemicals reported revenue of ₹239 crore and net profit of ₹21 crore, against ₹306 crore and ₹29 crore a year earlier.

Neogen Chemicals annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Neogen Chemicals annual profit and loss (₹ crore)
ItemMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue239306336487660671756848926
Expenses196248272401549561619711771
Operating profit43586487112110137137155
Operating margin %18%19%19%18%17%16%18%16%17%
Other income1001-13-21-89
Interest121214192438386183
Depreciation357121623282830
Profit before tax294144577153504150
Tax %28%30%29%22%30%32%31%30%29%
Net profit212931455036352936
EPS (₹)0.000.0012.5617.9020.0413.5113.2010.9013.48
Dividend payout %—————————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Neogen Chemicals financial results — frequently asked questions

What is Neogen Chemicals' annual revenue and net profit?

For the financial year ended Mar 2019, Neogen Chemicals' revenue was ₹239 crore and net profit ₹21 crore; net profit fell 27.59% from ₹29 crore in Mar 2020.

How fast has Neogen Chemicals grown over three years?

From Mar 2022 to Mar 2019, Neogen Chemicals' revenue grew at a compound annual rate of -21.1% and net profit at -22.4%. Past growth does not indicate future results.

What is the EPS of Neogen Chemicals?

Annual EPS for Mar 2019 was ₹0.00.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Neogen Chemicals With ATS

Track NEOGEN live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.